2015 to 2022 Saw Rise in Ketamine Use

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 14, 2025.

By Lori Solomon HealthDay Reporter

TUESDAY, Jan. 14, 2025 -- There have been shifts in both the patterns and correlates of ketamine use from 2015 to 2022, according to a study published online Jan. 7 in the Journal of Affective Disorders.

Kevin H. Yang, M.D., from the University of California, San Diego, and colleagues used data from the 2015 to 2022 National Survey on Drug Use and Health to examine trends in past-year ketamine use by depression status.

The researchers found that overall ketamine use prevalence increased from 2015 to 2019 (from 0.11 to 0.20 percent; an 81.8 percent increase) and from 2021 to 2022 (from 0.20 to 0.28 percent; a 40.0 percent increase). Use increased from 2015 to 2019 among adults with and without depression (by 139.3 and 66.7 percent, respectively). From 2021 to 2022, an increase occurred only among those without depression (by 38.9 percent). Depression was associated with increased odds of ketamine use in the 2015 to 2019 period (adjusted odds ratio, 1.80) but not in later years. From 2021 to 2022, adults aged 26 to 34 years and those with a college degree had higher odds for use. Higher odds of use were also consistently seen with use of various other drugs, including ecstasy/MDMA and gamma-hydroxybutyrate.

"Monitoring of use patterns is crucial to inform prevention and harm reduction strategies," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-15 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords